Toft-Nielsen M, Madsbad S, Holst J (2001). "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes". J Clin Endocrinol Metab. 86 (8): 3853–60. doi:10.1210/jc.86.8.3853. PMID11502823.Pemeliharaan CS1: Banyak nama: authors list (link)
Meier J, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck M, Holst J, Schmidt W, Gallwitz B (2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Crit Care Med. 32 (3): 848–51. doi:10.1097/01.CCM.0000114811.60629.B5. PMID15090972.Pemeliharaan CS1: Banyak nama: authors list (link)
Toft-Nielsen M, Madsbad S, Holst J (2001). "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes". J Clin Endocrinol Metab. 86 (8): 3853–60. doi:10.1210/jc.86.8.3853. PMID11502823.Pemeliharaan CS1: Banyak nama: authors list (link)
Meier J, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck M, Holst J, Schmidt W, Gallwitz B (2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Crit Care Med. 32 (3): 848–51. doi:10.1097/01.CCM.0000114811.60629.B5. PMID15090972.Pemeliharaan CS1: Banyak nama: authors list (link)